Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?

被引:2
作者
Tranchant, C [1 ]
Guiraud-Chaumeil, C [1 ]
Echaniz-Laguna, A [1 ]
Warter, JM [1 ]
机构
[1] Hop Univ Strasbourg, Serv Malad Syst Nerveux & Muscle, F-67091 Strasbourg, France
关键词
multiple system atrophy; Parkinson's disease; clonidine;
D O I
10.1007/s004150070072
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Clonidine, a centrally active alpha (2)-adrenoreceptor agonist used to lower blood pressure, has been proposed to differentiate central from peripheral autonomic deficits and multiple system atrophy (MSA) from untreated idiopathic Parkinson's disease (IPD). A lack of growth hormone (GH) increase after clonidine infusion is found in patients with MSA, but not in those with IPD or with pure autonomic failure. We studied 19 IPD and 7 MSA patients to assess whether this test could be used in clinical practice to distinguish MSA from IPD, whatever the stage of the disease. Serum GH levels were measured 15, 30, 45 and 60 min after a 10-min infusion of 2 mug/kg clonidine. GH levels remained stable after clonidine infusion in all 7 MSA patients but increased in only 12 of the 19 IPD patients, while remaining stable in the other 7. No correlation was found with the presence of orthostatic hypotension. We conclude that the GH response to clonidine infusion has a very high sensitivity (100% in our series and in previous studies) for the diagnosis of MSA. However, this response cannot be used as a diagnostic test because of its poor specificity.
引用
收藏
页码:853 / 856
页数:4
相关论文
共 23 条
  • [1] American Psychiatric Association, 1996, DSM 4 MAN DIAGN STAT
  • [2] Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure
    Benarroch, EE
    Smithson, IL
    Low, PA
    Parisi, JE
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (02) : 156 - 163
  • [3] Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy
    Braune, S
    Reinhardt, M
    Schnitzer, R
    Riedel, A
    Lücking, CH
    [J]. NEUROLOGY, 1999, 53 (05) : 1020 - 1025
  • [4] BROOKS DJ, 1997, MOVEMENT DISORD, V12, P826
  • [5] Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease
    Clarke, CE
    Ray, PS
    Speller, JM
    [J]. LANCET, 1999, 353 (9161) : 1329 - 1330
  • [6] SOME SPECIFIC CLINICAL-FEATURES DIFFERENTIATE MULTIPLE SYSTEM ATROPHY (STRIATONIGRAL VARIETY) FROM PARKINSONS-DISEASE
    COLOSIMO, C
    ALBANES, A
    HUGHES, AJ
    DEBRUIN, VMS
    LEES, AJ
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (03) : 294 - 298
  • [7] Neuropathology of Parkinson's disease
    Forno, LS
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (03) : 259 - 272
  • [8] PLASMA DOPA LEVELS AND GROWTH-HORMONE RESPONSE TO LEVODOPA IN PARKINSONISM
    GALEADEBONO, A
    JENNER, P
    MARSDEN, CD
    PARKES, JD
    TARSY, D
    WALTERS, J
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (02) : 162 - 167
  • [9] Consensus statement on the diagnosis of multiple system atrophy
    Gilman, S
    Low, P
    Quinn, N
    Albanese, A
    Ben-Shlomo, Y
    Fowler, C
    Kaufmann, H
    Klockgether, T
    Lang, A
    Lantos, P
    Litvan, I
    Mathias, C
    Oliver, E
    Robertson, D
    Schatz, I
    Wenning, G
    [J]. CLINICAL AUTONOMIC RESEARCH, 1998, 8 (06) : 359 - 362
  • [10] NEUROPATHOLOGY OF IMMUNOHISTOCHEMICALLY IDENTIFIED BRAIN-STEM NEURONS IN PARKINSONS-DISEASE
    HALLIDAY, GM
    LI, YW
    BLUMBERGS, PC
    JOH, TH
    COTTON, RGH
    HOWE, PRC
    BLESSING, WW
    GEFFEN, LB
    [J]. ANNALS OF NEUROLOGY, 1990, 27 (04) : 373 - 385